![Page 2: Nabila E. Metwalli MD PhD metwallin@emro.who.int 1](https://reader036.vdocuments.site/reader036/viewer/2022082709/56649d035503460f949d6aa4/html5/thumbnails/2.jpg)
2
BTS NRAs in the EMR Process Started by QA Workshop in Blood &
Plasma Establishments; EMRO, 2006 Followed by GMP Workshop in Blood &
Plasma Establishments; Tehran, Iran, 2009 Now preparing for Training of Inspectors on
GMP Workshop; 2013
![Page 3: Nabila E. Metwalli MD PhD metwallin@emro.who.int 1](https://reader036.vdocuments.site/reader036/viewer/2022082709/56649d035503460f949d6aa4/html5/thumbnails/3.jpg)
3
Why NRAs? An autonomous body that regulates BTSs
from both the system & technical sides Absolutely necessary for Blood Safety NRAs are usually a National body, preferably
separate from MOH; as in Pharmaceutical & Vaccine NRAs
![Page 4: Nabila E. Metwalli MD PhD metwallin@emro.who.int 1](https://reader036.vdocuments.site/reader036/viewer/2022082709/56649d035503460f949d6aa4/html5/thumbnails/4.jpg)
4
Situation in EMR Most member states have Guidelines &
Policies, but lack Legislation or NRAs Kingdoms of SAA & Jordan have developed
FDAs, but currently involved in only pharmaceutical & vaccine regulation, with potential at expansion of their activities
Iran has a BTS Regulatory Authority
![Page 5: Nabila E. Metwalli MD PhD metwallin@emro.who.int 1](https://reader036.vdocuments.site/reader036/viewer/2022082709/56649d035503460f949d6aa4/html5/thumbnails/5.jpg)
5
Situation in EMR (cont.) Lack of NRAs causes availability of unsafe
blood & blood products in about half the member states; both in the public & private sectors
Fragmentation of BTSs under different umbrellas: MOH, MOD, MOHE, Private sector, etc……. is a bad omen for Blood Safety
![Page 6: Nabila E. Metwalli MD PhD metwallin@emro.who.int 1](https://reader036.vdocuments.site/reader036/viewer/2022082709/56649d035503460f949d6aa4/html5/thumbnails/6.jpg)
6
Situation in EMR (cont.) Counter-fractionation is the method most used to
produce Plasma-derived products in the region NRAs with master files are the best choice for
such procedures This excludes GCC member states that import
plasma derivatives in bulk procurements Extremely under-developed countries use FFP in
lieu of plasma derivatives, when available
![Page 7: Nabila E. Metwalli MD PhD metwallin@emro.who.int 1](https://reader036.vdocuments.site/reader036/viewer/2022082709/56649d035503460f949d6aa4/html5/thumbnails/7.jpg)
7
Who is Responsible for creation of NRAs?
Legislators (highest responsibility) MOH Inspectors from MOH if available Directors of BTSs QA officers in Blood & Plasma
Establishments
![Page 8: Nabila E. Metwalli MD PhD metwallin@emro.who.int 1](https://reader036.vdocuments.site/reader036/viewer/2022082709/56649d035503460f949d6aa4/html5/thumbnails/8.jpg)
8
Don’t you wish you had an NRA for Blood & Plasma Establishments in your country?
Thank you